Somapacitan was noninferior to somatropin in improving yearly growth rate in children born SGA, or with NS or ISS. Topline data were announced from a phase 3 trial evaluating somapacitan in pre ...

The unnamed player was found in possession of a pen-type dispenser containing somatropin at the age of 15. A player at the academy of a Premier League club has been banned until May 2021 for ...

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth ...

Sogroya showed 11.0 cm/year growth in SGA children vs 9.4 cm/year with low-dose somatropin and 11.1 cm/year with high-dose. In Noonan syndrome, Sogroya achieved 10.4 cm/year height gain vs 9.2 cm ...

Sandoz launches somatropin, the first-ever Japanese biosimilar, increasing access to key medicines in second largest global market Human growth hormone somatropin launch follows precedent-setting ...

The Novartis generics business, Sandoz, launched its recombinant human growth hormone somatropin, Somatropin BS S.C., in Japan. The company says the drug is the first ever biosimilar to be ...

Study NCT00190658 aims to compare the mean first year growth velocity of prepubertal children with SHOX deficiency treated with somatropin with the growth velocity of a control group of untreated ...

The FDA recently approved the first once-weekly somatropin injection for pediatric patients 1 year and older who have growth failure due to inadequate secretion of endogenous growth hormone (GH).

Story > The European Medicines Agency confirmed it is reviewing the safety of the growth hormone somatropin, the key ingredient in medicines made by Pfizer and Roche, but stressed that there is ...